237 related articles for article (PubMed ID: 24777709)
1. The prevalence of amblyogenic factors in children with persistent congenital nasolacrimal duct obstruction.
Eshraghi B; Akbari MR; Fard MA; Shahsanaei A; Assari R; Mirmohammadsadeghi A
Graefes Arch Clin Exp Ophthalmol; 2014 Nov; 252(11):1847-52. PubMed ID: 24777709
[TBL] [Abstract][Full Text] [Related]
2. Anisometropia and refractive status in children with congenital nasolacrimal duct obstruction-a prospective observational study.
Hareendran H; Allapitchai F; Ravindran M; Shukul K; Rengappa R
J AAPOS; 2022 Apr; 26(2):76.e1-76.e4. PubMed ID: 35314316
[TBL] [Abstract][Full Text] [Related]
3. Amblyopia Risk Factors in Newborns With Congenital Nasolacrimal Duct Obstruction.
Vagge A; Tulumello C; Pellegrini M; Di Maita M; Iester M; Traverso CE
J Pediatr Ophthalmol Strabismus; 2020 Jan; 57(1):39-43. PubMed ID: 31972039
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of amblyopia in children undergoing nasolacrimal duct irrigation and probing.
Ozgur OR; Sayman IB; Oral Y; Akmaz B
Indian J Ophthalmol; 2013 Dec; 61(12):698-700. PubMed ID: 24413822
[TBL] [Abstract][Full Text] [Related]
5. Anisometropia and Refractive Status in Children with Bilateral Congenital Nasolacrimal Duct Obstruction.
Siddiqui SN; Hannan A; Mansoor H; Asif M; Wakeel U
J Coll Physicians Surg Pak; 2018 Mar; 28(3):210-213. PubMed ID: 29544578
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Anisometropia and Refractive Status in Children With Unilateral and Bilateral Congenital Nasolacrimal Duct Obstruction.
Siddiqui SN; Mansoor H; Asif M; Wakeel U; Saleem AA
J Pediatr Ophthalmol Strabismus; 2016 May; 53(3):168-72. PubMed ID: 27224951
[TBL] [Abstract][Full Text] [Related]
7. Neonatal dacryostenosis as a risk factor for anisometropia.
Piotrowski JT; Diehl NN; Mohney BG
Arch Ophthalmol; 2010 Sep; 128(9):1166-9. PubMed ID: 20837801
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Endoscopically Assisted Primary Probing and Bicanalicular Silicone Intubation for Congenital Nasolacrimal Duct Obstruction in Children Aged 4 to 7 Years.
Arici C; Mergen B; Ozan T; Batu Oto B
J Pediatr Ophthalmol Strabismus; 2023; 60(2):101-107. PubMed ID: 35446188
[TBL] [Abstract][Full Text] [Related]
9. Amblyopia risk factors in congenital nasolacrimal duct obstruction: A longitudinal case-control study.
Yoo Y; Yang HK; Kim N; Choung HK; Hwang JM; Khwarg SI
PLoS One; 2019; 14(6):e0217802. PubMed ID: 31194774
[TBL] [Abstract][Full Text] [Related]
10. High incidence and recurrence of tympanostomy tube procedures in children who underwent nasolacrimal duct probe and intubation for congenital nasolacrimal duct obstruction.
Vicinanzo MG; Cooper KM; Gerber AL; Long J; McGwin G
J AAPOS; 2023 Oct; 27(5):286.e1-286.e4. PubMed ID: 37734706
[TBL] [Abstract][Full Text] [Related]
11. Congenital nasolacrimal duct obstruction: common management policies among pediatric ophthalmologists.
Dotan G; Nelson LB
J Pediatr Ophthalmol Strabismus; 2015; 52(1):14-9. PubMed ID: 25365513
[TBL] [Abstract][Full Text] [Related]
12. Amblyopia risk factors in infants with congenital nasolacrimal duct obstruction.
Kim JW; Lee H; Chang M; Park M; Lee TS; Baek S
J Craniofac Surg; 2013 Jul; 24(4):1123-5. PubMed ID: 23851753
[TBL] [Abstract][Full Text] [Related]
13. A comparison of the success rates of endoscopic-assisted probing in the treatment of membranous congenital nasolacrimal duct obstruction between younger and older children and its correlation with the thickness of the membrane at the Valve of Hasner.
Gupta N; Neeraj C; Smriti B; Sima D
Orbit; 2018 Aug; 37(4):257-261. PubMed ID: 29040026
[TBL] [Abstract][Full Text] [Related]
14. Nasolacrimal duct obstruction: Does it really increase the risk of amblyopia in children?
Ramkumar VA; Agarkar S; Mukherjee B
Indian J Ophthalmol; 2016 Jul; 64(7):496-9. PubMed ID: 27609160
[TBL] [Abstract][Full Text] [Related]
15. Unilateral Congenital Nasolacrimal Duct Obstruction, Is It An Amblyogenic Factor?
AlHammad F; Al Tamimi E; Yassin S; AlBadri K; AlJarudi S; AlShawaf M; Khandekar R
Middle East Afr J Ophthalmol; 2018; 25(3-4):156-160. PubMed ID: 30765954
[TBL] [Abstract][Full Text] [Related]
16. Co-existing lacrimal drainage anomalies in eyes with congenital Glaucoma.
Senthil S; Ali MJ; Chary R; Mandal AK
Eur J Ophthalmol; 2022 Sep; 32(5):2683-2687. PubMed ID: 35018871
[TBL] [Abstract][Full Text] [Related]
17. [Congenital nasolacrimal duct obstruction from an ophthalmologist's point of view : Causes, diagnosis and staged therapeutic concept].
Heichel J; Bredehorn-Mayr T; Struck HG
HNO; 2016 Jun; 64(6):367-75. PubMed ID: 26912049
[TBL] [Abstract][Full Text] [Related]
18. Success rates of dacryoendoscopy-guided probing for recalcitrant congenital nasolacrimal duct obstruction.
Fujimoto M; Ogino K; Matsuyama H; Miyazaki C
Jpn J Ophthalmol; 2016 Jul; 60(4):274-9. PubMed ID: 27116947
[TBL] [Abstract][Full Text] [Related]
19. Pushed monocanalicular intubation versus probing for the treatment of simple and incomplete complex types of congenital nasolacrimal duct obstruction in children older than 18 months old.
Eshraghi B; Khalilipour E; Ameli K; Bazvand F; Mirmohammadsadeghi A
Orbit; 2017 Aug; 36(4):218-222. PubMed ID: 28627958
[TBL] [Abstract][Full Text] [Related]
20. A prospective, randomised comparison of probing versus bicanalicular silastic intubation for congenital nasolacrimal duct obstruction.
Al-Faky YH; Mousa A; Kalantan H; Al-Otaibi A; Alodan H; Alsuhaibani AH
Br J Ophthalmol; 2015 Feb; 99(2):246-50. PubMed ID: 25185252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
